文献速递妇科

高级别浆液性癌恶性积液中多细胞球体的短期类器官培养用于药物敏感性检测

Short-term organoid culture for drug sensitivity testing of high-grade serous carcinoma.
PubMed 文献 · Gynecol Oncol · 2020-04-04

本研究从高级别浆液性卵巢癌患者的恶性积液中回收多细胞球体,在支持类器官生长的条件下进行短期培养,数天内形成类器官并可扩增至少6天。对4例标本的RNA测序显示培养6天内增殖、上皮间质转化和KRAS信号通路相关基因显著上调,所有标本均完成药物敏感性检测并识别出有治疗潜力的药物。结论认为该短期类器官培养平台可用于经验性药物敏感性检测。

要点

  • 恶性积液中的多细胞球体可在数天内形成类器官,并扩增至少6天。
  • 培养6天内增殖、上皮间质转化及KRAS信号通路相关基因显著上调。
  • 该平台可用于经验性药物敏感性检测,辅助筛选治疗药物。

核心结论

  • 高级别浆液性卵巢癌恶性积液来源的多细胞球体短期类器官培养可作为经验性药物敏感性检测平台。

研究设计与样本

  • 收集高级别浆液性卵巢癌患者恶性积液标本,回收多细胞球体并在支持类器官生长的条件下培养。
  • 对部分标本在短期培养的两个时间点进行RNA测序,并用Ki67染色和组织学分析表征类器官诱导。
  • 对所有标本进行药物敏感性检测。

主要发现

  • 类器官在原代培养数天内形成,可重现恶性腹水液的组织学特征,并可扩增至少6天。
  • 4例患者标本的RNA测序显示培养6天内细胞增殖、上皮间质转化和KRAS信号通路相关基因显著上调。
  • 药物敏感性检测识别出几种具有治疗潜力的药物。

临床怎么用

  • 可利用恶性积液标本进行短期类器官培养,开展经验性药物敏感性检测。
  • 该体外模型可能有助于在个体化治疗前筛选新药或现有治疗药物。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Cancer patient-derived organoids (PDOs) grow as three dimensional (3D) structures in the presence of extracellular matrix and have been found to represent the original tumor's genetic complexity. In addition, PDOs can be grown and subjected to drug sensitivity testing in a shorter time course and with lesser expense than patient-derived xenograft models. Many patients with recurrent ovarian cancer develop malignant effusions that become refractory to chemotherapy. Since these same patients often present for palliative aspiration of ascites or pleural effusions, there is a potential opportunity to obtain tumor specimens in the form of multicellular spheroids (MCS) present in malignant effusion fluids. Our objective was to develop a short duration culture of MCS from ovarian cancer malignant effusions in conditions selected to support organoid growth and use them as a platform for empirical drug sensitivity testing. METHODS: In this study, malignant effusion specimens were collected from patients with high-grade serous ovarian carcinoma (HGSOC). MCS were recovered and subjected to culture conditions designed to support organoid growth. In a subset of specimens, RNA-sequencing was performed at two time points during the short-term culture to determine changes in transcriptome in response to culture conditions. Organoid induction was also characterized in these specimens using Ki67 staining and histologic analysis. Drug sensitivity testing was performed on all specimens. RESULTS: Our model describes organoids formed within days of primary culture, which can recapitulate the histological features of malignant ascites fluid and can be expanded for at least 6 days. RNA-seq analysis of four patient specimens showed that within 6 days of culture, there was significant up-regulation of genes related to cellular proliferation, epithelial-mesenchymal transition, and KRAS signaling pathways. Drug sensitivity testing identified several agents with therapeutic potential. CONCLUSIONS: Short duration organoid culture of MCS from HGSOC malignant effusions can be used as a platform for empiric drug sensitivity testing. These ex vivo models may be helpful in screening new or existing therapeutic agents prior to individualized treatment options.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Chen H, Gotimer K, De Souza C, et al. Short-term organoid culture for drug sensitivity testing of high-grade serous carcinoma. Gynecol Oncol. 2020. PMID: 32253045. doi:10.1016/j.ygyno.2020.03.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。